NYSE:CLB Core Laboratories (CLB) Stock Price, News & Analysis $18.30 -0.06 (-0.33%) (As of 09/18/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Core Laboratories alerts: Email Address About Core Laboratories Stock (NYSE:CLB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Core Laboratories alerts:Sign Up Key Stats Today's Range$18.03▼$19.2050-Day Range$16.52▼$24.5352-Week Range$13.82▼$25.20Volume485,484 shsAverage Volume448,048 shsMarket Capitalization$858.27 millionP/E Ratio20.80Dividend Yield0.22%Price Target$18.00Consensus RatingReduce Company OverviewCore Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.Read More… Kamala Harris To Tank the Market? (Ad)URGENT ELECTION MELTDOWN WARNING From the former CIA advisor who predicted President Trump’s win in 2016…Click here now to see how to protect yourself. Core Laboratories Stock Analysis - MarketRank™See Top Rated MarketRank™ StocksOverall MarketRank™: 55th PercentileCore Laboratories scored higher than 55% of companies evaluated by MarketBeat, and ranked 178th out of 263 stocks in the oils/energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.8 / 5Analyst RatingReduce Consensus RatingCore Laboratories has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating.Amount of Analyst CoverageCore Laboratories has only been the subject of 3 research reports in the past 90 days.Read more about Core Laboratories' stock forecast and price target. Earnings and Valuation3.8 / 5Proj. Earnings Growth47.50% Earnings GrowthEarnings for Core Laboratories are expected to grow by 47.50% in the coming year, from $0.80 to $1.18 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is 20.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 134.82.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is 20.80, which means that it is trading at a more expensive P/E ratio than the Oils/Energy sector average P/E ratio of about 15.33.Price to Earnings Growth RatioCore Laboratories has a PEG Ratio of 0.94. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 3.72. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Core Laboratories' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted16.05% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 16.1, which indicates bearish sentiment.Change versus previous monthShort interest in Core Laboratories has recently decreased by 5.93%, indicating that investor sentiment is improving significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldCore Laboratories has a dividend yield of 0.24%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 4.55%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 3.39% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.Read more about Core Laboratories' dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted16.05% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 16.1, which indicates bearish sentiment.Change versus previous monthShort interest in Core Laboratories has recently decreased by 5.93%, indicating that investor sentiment is improving significantly. News and Social Media3.2 / 5News Sentiment0.76 News SentimentCore Laboratories has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Oils/Energy companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Core Laboratories this week, compared to 3 articles on an average week.Search Interest3 people have searched for CLB on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Core Laboratories to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.76% of the stock of Core Laboratories is held by insiders.Percentage Held by Institutions97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Core Laboratories' insider trading history. Receive CLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address CLB Stock News HeadlinesCore Laboratories (NYSE:CLB) Shares Gap Up to $17.00September 18 at 2:27 PM | americanbankingnews.comCore Laboratories (NYSE:CLB) Downgraded by StockNews.com to "Sell"September 18 at 4:57 AM | americanbankingnews.comKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… September 18, 2024 | Paradigm Press (Ad)Analysts Set Core Laboratories Inc. (NYSE:CLB) PT at $18.50September 13, 2024 | americanbankingnews.comEquities Analysts Issue Forecasts for Core Laboratories Inc.'s Q4 2025 Earnings (NYSE:CLB)September 10, 2024 | americanbankingnews.comCore Laboratories (CLB) Down 25.6% Since Last Earnings Report: Can It Rebound?August 23, 2024 | uk.finance.yahoo.comCore Laboratories (CLB) Rose After Earnings BeatAugust 22, 2024 | msn.comCore Laboratories Inc. (HJ1.F)August 14, 2024 | nz.finance.yahoo.comSee More Headlines CLB Stock Analysis - Frequently Asked Questions How have CLB shares performed this year? Core Laboratories' stock was trading at $17.66 on January 1st, 2024. Since then, CLB shares have increased by 3.6% and is now trading at $18.30. View the best growth stocks for 2024 here. How were Core Laboratories' earnings last quarter? Core Laboratories Inc. (NYSE:CLB) issued its quarterly earnings results on Wednesday, July, 24th. The oil and gas company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.21 by $0.01. The firm's quarterly revenue was up 2.1% compared to the same quarter last year. Who are Core Laboratories' major shareholders? Top institutional shareholders of Core Laboratories include Ariel Investments LLC (21.95%), Disciplined Growth Investors Inc. MN (9.51%), Earnest Partners LLC (7.01%) and Dimensional Fund Advisors LP (1.60%). View institutional ownership trends. How do I buy shares of Core Laboratories? Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX) and Intel (INTC). Company Calendar Last Earnings7/24/2024Ex-Dividend for 8/26 Dividend8/05/2024Dividend Payable8/26/2024Today9/18/2024Next Earnings (Estimated)11/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorOils/Energy Industry Oil & gas field services, not elsewhere classified Sub-IndustryPetroleum And Natural Gas Current SymbolNYSE:CLB CUSIPN/A CIK1000229 Webwww.corelab.com Phone(713) 328-2673FaxN/AEmployees3,600Year Founded1936Price Target and Rating Average Stock Price Target$18.00 High Stock Price Target$22.00 Low Stock Price Target$15.00 Potential Upside/Downside-3.4%Consensus RatingReduce Rating Score (0-4)1.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)$0.88 Trailing P/E Ratio21.18 Forward P/E Ratio23.30 P/E Growth0.94Net Income$36.67 million Net Margins5.44% Pretax Margin7.87% Return on Equity15.20% Return on Assets6.06% Debt Debt-to-Equity Ratio0.60 Current Ratio2.39 Quick Ratio1.68 Sales & Book Value Annual Sales$513.77 million Price / Sales1.70 Cash Flow$1.20 per share Price / Cash Flow15.56 Book Value$4.92 per share Price / Book3.79Miscellaneous Outstanding Shares46,900,000Free Float46,544,000Market Cap$874.22 million OptionableOptionable Beta2.37 Social Links 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report This page (NYSE:CLB) was last updated on 9/18/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredCrypto ‘Banana Zone’ Incoming…What if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Core Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.